CORPORATE SOCIAL RESPONSIBILITY AND FINANCIAL PERFORMANCE OF PHARMACEUTICAL FIRMS IN NIGERIA (A STUDY OF JUHEL PHARMACEUTICAL COMPANY LTD)

ABSTRACT This study examined the relationship berween corporate Social Responsibility and financial performance of pharmaceutical firms in Nigeria.Specifically, study aimed the effect of Environmental cost,Staff cost Gμd Corporate Donations on Return on Asset(ROA)of pharmaceutical firms in Nigeria.An ex-post facto research design approach was adopted for the study.The population of this study comprise of the pharmaceutical firms in Nigeria.Using time series data for the period of six (6)years (20172022)and a purposive sampling method, Juhel Pharmaceutical Company Ltd was chosen as the sample size.Secondary data were carefully sourced from the financial statementsor 2017 to 2022 obtained from the company fixed base in Enugu and the company's website.The data collected were presented and analyzed using tables,descriptive and inferential statisti.Three hypotheses were formulated and tested in the course of this study.Regression analysis was used to test for statistical significance of the effects of corporate social responsibiliry 2counting on financial performance in pharmaceutical fir in Nigeria.The results Bwed that there is significant effect of Environmental cost on the Return on Asset (ROA)of pharmaceutical firmin Nigeria.The findings further revealed that there is no significant effect of Staff cost on the Eeturn on Asset (ROA)of pharmaceutical firms in Nigeria.Finally,the result established also that there is no significant effect o6Corporate Donations on the Return on Asset (ROA)of of pharmaceutical firms in Nigeria.Consequent upon the findings,this study recommends among others;that the government should review its policy on corporate social responsibility to fine-tune firms concerns on enviromment that they will be more responsible citizen.